
Innovative methods of gastroretentive sustained-release drug delivery
CARVEDILOL GASTRORETENTIVE DRUGS DELIVERY SYSTEM DESIGN AND IN VITRO CHARACTERIZATION
Versandkostenfrei!
Versandfertig in 6-10 Tagen
29,99 €
inkl. MwSt.
PAYBACK Punkte
15 °P sammeln!
The current study's objective is to create and evaluate an effervescent-based sustained-release floating drug delivery system (FDDS) for carvedilol that has a 12-hour dissolving time to reduce the frequency of its administration. Over the past 20 years, there has been a huge desire for more dosage forms that are acceptable to patients. Because of this, their technologies are more in demand than ever. Since creating a new chemical entity is very expensive, pharmaceutical companies are focusing on creating novel drug delivery systems for their existing medications that have improved efficacy and...
The current study's objective is to create and evaluate an effervescent-based sustained-release floating drug delivery system (FDDS) for carvedilol that has a 12-hour dissolving time to reduce the frequency of its administration. Over the past 20 years, there has been a huge desire for more dosage forms that are acceptable to patients. Because of this, their technologies are more in demand than ever. Since creating a new chemical entity is very expensive, pharmaceutical companies are focusing on creating novel drug delivery systems for their existing medications that have improved efficacy and bioavailability, along with a lower dose frequency to lessen side effects.